Department of Ophthalmology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Medicine (Baltimore). 2024 Mar 1;103(9):e37333. doi: 10.1097/MD.0000000000037333.
Ophthalmologists mainly treat epithelial ingrowth by lifting the flap and scraping the ingrowth or using scraping combined with phototherapeutic keratectomy, mitomycin C, and so on. The potential usefulness of nonsteroidal anti-inflammatory drugs in such circumstances has not been reported before.
A 32-year-old man and a 25-year-old man underwent lifting and scraping of the flap and phototherapeutic keratectomy to remove the epithelial ingrowths. Unfortunately, the ingrowths recurred and continued to develop.
The patients were diagnosed with corneal epithelial ingrowth.
The administration of bromfenac sodium and fluorometholone eye drops.
Epithelial ingrowths in both patients disappeared after 6 and 1 month of treatment, respectively. There were no adverse reactions to the eye drops.
Nonsteroidal anti-inflammatory drugs may be broadly applied in the treatment of epithelial ingrowth after laser in situ keratomileusis.
眼科医生主要通过掀起角膜瓣并刮除赘生物，或采用刮除联合光动力角膜切削术、丝裂霉素 C 等方法治疗角膜上皮内植入物。然而，此前尚未有研究报道非甾体类抗炎药在这种情况下的潜在用途。
两名患者，分别为 32 岁男性和 25 岁男性，均接受了掀起角膜瓣和光动力角膜切削术以去除角膜上皮内植入物。遗憾的是，植入物复发并持续发展。
患者被诊断为角膜上皮内植入物。
给予溴芬酸钠和氟米龙滴眼液滴眼。
两名患者在接受治疗 6 个月和 1 个月后，角膜上皮内植入物均消失，且未见滴眼液相关不良反应。
非甾体类抗炎药可能广泛应用于激光原位角膜磨镶术后角膜上皮内植入物的治疗。
